author-photo

Brigitte Gehrke

3

Papers

113

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl–positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571)

2003 Blood
Show All
- Source
- Cite
- Save
Citations (74)
Early Minimal Residual Disease (MRD) Analysis During Treatment of Philadelphia Chromosome / Bcr -Abl Positive Acute Lymphoblastic Leukemia (Ph + ALL) with the Abl -Tyrosine Kinase Inhibitor STI571 (Glivec) Running title: MRD Analysis in Ph + ALL During STI571 T reatment

2002
Show All
- Source
- Cite
- Save
Citations (0)